L1CAM Promotes the Infiltrative Properties of Patient-Derived Glioblastoma Cells.
Saved in:
| Title: | L1CAM Promotes the Infiltrative Properties of Patient-Derived Glioblastoma Cells. |
|---|---|
| Authors: | Katsuma A; Division of Regenerative Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.; Laboratory of Systems Neurobiology and Medicine, Division of Biological Science, Nara Institute of Science and Technology, Ikoma, Nara, Japan., Kanematsu D; Division of Molecular Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan., Handa Y; Division of Regenerative Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan., Shofuda T; Division of Stem Cell Research, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan., Yamamoto A; Division of Stem Cell Research, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan., Nishitani K; Department of Neuro-Oncology, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry, Tokyo, Japan., Xiao Z; Department of Neuro-Oncology, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan., Kawauchi D; Department of Neuro-Oncology, Institute of Brain Science, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan.; Department of Biochemistry and Cellular Biology, National Center of Neurology and Psychiatry, Tokyo, Japan., Baba K; Laboratory of Systems Neurobiology and Medicine, Division of Biological Science, Nara Institute of Science and Technology, Ikoma, Nara, Japan.; Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Inagaki N; Laboratory of Systems Neurobiology and Medicine, Division of Biological Science, Nara Institute of Science and Technology, Ikoma, Nara, Japan., Kanemura Y; Division of Regenerative Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.; Division of Molecular Medicine, Department of Biomedical Research and Innovation, Institute for Clinical Research, NHO Osaka National Hospital, Osaka, Japan.; Department of Neurosurgery, NHO Osaka National Hospital, Osaka, Japan. |
| Source: | Cancer science [Cancer Sci] 2026 May; Vol. 117 (5), pp. 1380-1396. Date of Electronic Publication: 2026 Mar 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1349-7006 |
|---|---|
| DOI: | 10.1111/cas.70359 |
